Steven C. Zielinski, MD, CM, FRCSC
Diplomate of the American Board of Neurological Surgery
- Founder & CEO, Texas Spine & Neurosurgery
- Founder & CEO Oklahoma Spine & Neurosurgery
- Founder & CEO American Spine & Neurosurgery
-
Founder & CEO, Zielinski Medical Technologies
- Founder & Editor in Chief, Texas Spine and Neurosurgery Journal
Oklahoma Hospital Affiliation
- Lawton: Southwestern Medical Center
Education & Credentials
Education:
- 2006 – Diplomate of the American Board of Neurological Surgeons
- 2003 – F.R.C.S.C., Royal College of Physicians and Surgeons of Canada, Ontario, Canada
- 2001-2002 – Stanford University, California, Vascular Neurosurgery
- 1995 – M.D. C.M., McGill University, Montreal, Canada
- 1991 – Pre-Medical Program, McGill University, Montreal, Canada
Awards & Honors:
- 2003 – Money Magazine: Ranked First in Back & Neck Surgery on West Coast of the U.S.A.
- 1990-1995 – Dean’s List, McGill University
- 1990-1994 – Pratt and Whitney Scholarship, GPA of 3.5 +
- 1993 – J.W. McConnell Award, Top 5% of Medical Class
Medical Licensure:
- 2007-present – State of Texas
Experience
Professional Experience:
- 2023 – present: Founder & CEO, Oklahoma Spine & Neurosurgery, Oklahoma
- 2023 – present: Founder & CEO, American Spine & Neurosurgery, Texas and Oklahoma
- 2016 – present: Founder & Editor in Chief, Texas Spine and Neurosurgery Journal, Texas
- 2010 – present: Founder & CEO, Texas Spine & Neurosurgery, Texas
- 2008 – present: Founder & CEO, Zielinski Medical Technologies, Texas
- 2007 – present: Neurosurgeon, Texas
- 2004 – 2007: Neurosurgeon, Colorado
- 2002 – 2004: Neurosurgeon, California
Fellowships/Residences:
- 2001-2002 – Cerebrovascular Fellowship, Stanford University, Palo Alto, California
- 1995-2001 – Neurosurgical Residency, Montreal Neurological Hospital, Montreal, Canada
Publications, Presentations & Research
Publications:
- “Heat Shock Protein Immunoreactivity in CSF: Correlation with Oligoclonal Banding and Demyelinating Disease,” S.Prabhakar, M.B.; E. Kurien, M.D.; R.S. Gupta, Ph.D.; S. Zielinski; and M.S. Freedman, M.D., Neurology, Volume 44, Number 9, September, 1994.
- “Reactivity of Anti-GM1 Antibodies with Peripheral Nerve: Correlation with Clinical Phenotype,” Submitted, 2nd Author, 1994.
Presentations:
- “Carotid Endarterectomy: Short and Long term Re-Stenosis in Patched versus Non-Patched Patients,” 2002 Annual Meeting AANS: S. Zielinski M.D. C.M., S.D.Chang M.D., G.K. Steinberg, M.D., Ph.D.
Funded Grants and Research:
- 1999 – Mechanisms of Astrocyte Proliferation, Growth & Process Formation, Supervised By: Dr. Jack Antel, David Kaplan, Ph.D.
- 1992 – Immunohistochemical Characteristics of Anti-Nerve Antibodies in Clinical Motor Neuropathies, Montreal Neurological Hospital, Supervised By: Dr. Mark Freedman
- 1991 – Anti-Mag Antibody Staining Patterns in Peripheral Nerve Tissue, Montreal Neurological Hospital, Supervised By: Dr. Mark Freedman
- 1991 – The Role of Antibodies in the Pathogenesis of Peripheral Neuropathies, Montreal Neurological Hospital, Supervised By: Dr. Mark Freedman
Other Information
LANGUAGES: English & French
HOBBIES & INTERESTS:
- Skiing
- Wakeboarding
- Scuba Diving, PADI Certified
- Martial Arts, Ju Jitsu & Kali
- Pilot IFR, Multi Engine, Commercial Rating
